These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 20677557)
1. [Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors]. Li F; Zhong Z; Li R; Huang H; Wang L; Zheng D; Zhang D Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):317-21. PubMed ID: 20677557 [TBL] [Abstract][Full Text] [Related]
2. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947 [TBL] [Abstract][Full Text] [Related]
3. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors. Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584 [TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas. Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827 [TBL] [Abstract][Full Text] [Related]
5. Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung. Miki M; Ball DW; Linnoila RI Lung Cancer; 2012 Jan; 75(1):58-65. PubMed ID: 21684625 [TBL] [Abstract][Full Text] [Related]
6. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features. Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117 [TBL] [Abstract][Full Text] [Related]
7. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung. Nasgashio R; Sato Y; Matsumoto T; Kageyama T; Hattori M; Iyoda A; Satoh Y; Ryuge S; Masuda N; Jiang SX; Saegusa M Lung Cancer; 2011 Dec; 74(3):405-10. PubMed ID: 21601304 [TBL] [Abstract][Full Text] [Related]
8. P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738 [TBL] [Abstract][Full Text] [Related]
9. Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases. La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C Hum Pathol; 2013 Jul; 44(7):1391-9. PubMed ID: 23375646 [TBL] [Abstract][Full Text] [Related]
10. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674 [TBL] [Abstract][Full Text] [Related]
11. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells. Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of adjacent CpG sites is negatively correlated with the expression of lineage oncogene ASCL1 in pulmonary neuroendocrine tumors. Truong N; Chun SM; Kim TI; Suh YA; Jang SJ Tumour Biol; 2017 Jun; 39(6):1010428317706225. PubMed ID: 28621224 [TBL] [Abstract][Full Text] [Related]